Wall Street analysts predict that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will post earnings of $0.66 per share for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings. The highest EPS estimate is $0.73 and the lowest is $0.59. DENTSPLY SIRONA reported earnings of $0.76 per share in the same quarter last year, which would indicate a negative year over year growth rate of 13.2%. The firm is scheduled to report its next quarterly earnings results before the market opens on Wednesday, August 9th.

On average, analysts expect that DENTSPLY SIRONA will report full-year earnings of $2.83 per share for the current fiscal year, with EPS estimates ranging from $2.80 to $2.88. For the next financial year, analysts forecast that the company will post earnings of $3.21 per share, with EPS estimates ranging from $3.05 to $3.39. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by $0.01. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The business had revenue of $900.50 million during the quarter, compared to analyst estimates of $916.55 million. During the same quarter in the prior year, the company posted $0.69 EPS. The company’s quarterly revenue was up 16.6% compared to the same quarter last year.

XRAY has been the subject of a number of recent research reports. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, April 12th. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their target price for the company from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. BidaskClub cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, June 10th. Finally, HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $67.92.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Expect DENTSPLY SIRONA Inc. (XRAY) Will Post Earnings of $0.66 Per Share” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/07/zacks-brokerages-expect-dentsply-sirona-inc-xray-will-post-earnings-of-0-66-per-share.html.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) traded up 1.22% during trading on Wednesday, hitting $62.34. 1,587,755 shares of the stock were exchanged. The firm’s 50-day moving average is $63.88 and its 200 day moving average is $62.25. DENTSPLY SIRONA has a 1-year low of $55.00 and a 1-year high of $65.68. The company has a market cap of $14.29 billion, a P/E ratio of 40.12 and a beta of 1.26.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 22.58%.

A number of hedge funds and other institutional investors have recently bought and sold shares of XRAY. Dupont Capital Management Corp bought a new position in DENTSPLY SIRONA during the second quarter worth approximately $116,000. Korea Investment CORP increased its position in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares during the period. Howard Hughes Medical Institute increased its position in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,580 shares during the period. Penserra Capital Management LLC increased its position in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the period. Finally, Howland Capital Management LLC bought a new position in DENTSPLY SIRONA during the first quarter worth approximately $203,000. 95.17% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.